Add BrightSurf on Google Email

Brigham and Women's Hospital


Eat 'em up: Next-generation therapeutic helps immune cells detect, destroy cancer

Researchers at Brigham and Women's Hospital have developed a supramolecular therapeutic that blocks the 'eat me not' signal sent by cancer cells and converts macrophages to the attacking M1 subtype. The approach has yielded promising results in preclinical models, showing complete inhibition of tumor growth and increased survival rates.

SourceBrigham and Women's Hospital·JournalNature Biomedical Engineering·DateJul 2, 2018

Accurate measurements of sodium intake confirm relationship with mortality

A new study by Brigham and Women's Hospital confirms the relationship between sodium intake and increased risk of cardiovascular disease and death. The research suggests that an imprecise evaluation of sodium intake may have contributed to paradoxical results in previous studies, emphasizing the importance of accurate measurement methods.

SourceBrigham and Women's Hospital·JournalInternational Journal of Epidemiology·DateJun 21, 2018

Insufficient sleep, even without extended wakefulness, leads to performance impairments

Chronic short sleep duration, independent of extended wakefulness, results in vigilant performance impairments, with attention lapses increasing fivefold and reaction time doubling. Participants on restricted sleep schedules worsened over time, suggesting they cannot adapt to chronically insufficient sleep.

SourceBrigham and Women's Hospital·JournalProceedings of the National Academy of Sciences·DateMay 21, 2018

Re-assessing organ availability

Researchers at Brigham and Women's Hospital are re-assessing organ availability by considering previously deemed 'unfit' organs. The study aims to expand the donor pool and improve transplant outcomes, with the potential to save more lives.

SourceBrigham and Women's Hospital·JournalNew England Journal of Medicine·DateMay 16, 2018

How the gut influences neurologic disease

A study published in Nature sheds light on the connection between the gut and brain, revealing a new pathway that may help guide therapies for multiple sclerosis and other neurologic diseases. Researchers found that compounds produced by gut microbes can limit inflammation in the brain through their influence on microglia.

SourceBrigham and Women's Hospital·JournalNature·DateMay 16, 2018

New tool predicts deadly form of rare cancer

A new tool uses high-throughput DNA sequencing to accurately predict which early-stage Cutaneous T Cell Lymphoma (CTCL) patients are at risk of developing an aggressive form of the disease. The tool, which analyzes specific genes, has shown promise in improving treatment outcomes for these patients.

SourceBrigham and Women's Hospital·JournalScience Translational Medicine·DateMay 9, 2018

Automated notification system improves follow-up of actionable tests pending at discharge

A new study by researchers from Brigham and Women's Hospital demonstrates that implementing an automated notification system can improve the follow-up of actionable tests pending at discharge. The system significantly improved the time to documented action for these tests, with patients receiving follow-up on their results much faster.

SourceBrigham and Women's Hospital·JournalJournal of General Internal Medicine·DateMar 21, 2018

Canakinumab reduces risk of cardiovascular events in populations with unmet clinical need

A new analysis found that canakinumab substantially reduced cardiovascular event rates among patients with diabetes and those with moderate to severe chronic kidney disease. The drug also showed benefits in reducing rates of major adverse cardiovascular events among high-risk atherosclerotic patients.

SourceBrigham and Women's Hospital·JournalJournal of the American College of Cardiology·DateMar 12, 2018

New cardiac pump device improves long-term outcomes for heart failure patients

The MOMENTUM 3 clinical trial found that advanced heart-failure patients who received a centrifugal-flow circulatory pump had significantly lower rates of pump-related blood clots and stroke compared to those receiving an axial flow pump. Patients who received the centrifugal-flow pump also had fewer re-operations due to device malfunc...

SourceBrigham and Women's Hospital·JournalNew England Journal of Medicine·DateMar 11, 2018